| Trial ID: | L7068 |
| Source ID: | NCT04660305
|
| Associated Drug: |
At278
|
| Title: |
AT278 and NovoRapid® in Glucose Clamp Study
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: AT278|DRUG: NovoRapid
|
| Outcome Measures: |
Primary: Area under the glucose infusion-rate curve of insulin aspart, 0 - 8 hours |
|
| Sponsor/Collaborators: |
Sponsor: Arecor Limited
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
38
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2020-12-02
|
| Completion Date: |
2021-06-11
|
| Results First Posted: |
|
| Last Update Posted: |
2021-07-21
|
| Locations: |
Clinical Trials Unit, Medical University of Graz, Graz, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT04660305
|
